Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Colostro-Noni is an orally administered dietary supplement developed by Guna S.p.a., combining freeze-dried bovine colostrum and Morinda citrifolia (Noni) juice. It is designed to support the integrity of the intestinal mucosa and modulate the gut microbiota. Bovine colostrum provides a rich source of immunoglobulins, growth factors (such as Transforming growth factor beta), and lactoferrin, which help maintain the intestinal barrier and regulate local immune responses. Noni juice contributes antioxidant and anti-inflammatory properties, potentially enhancing the regenerative effects on the intestinal epithelium. The supplement is primarily used to manage intestinal inflammation, dysbiosis, and conditions associated with increased intestinal permeability, often referred to as leaky gut syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Colostro-Noni.